All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Hepatitis B, Chronic-24316031

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	24316031	C69X	S	S	Hepatitis B, Chronic	G L	View
2	24316031	S78T	RT	P	Hepatitis B, Chronic	G S L	View
3	24316031	E164D	S	S	Hepatitis B, Chronic	G L	View
4	24316031	G44E	S	S	Hepatitis B, Chronic	G L	View
5	24316031	H55Q	RT	P	Hepatitis B, Chronic	G S L	View
6	24316031	H55R	RT	P	Hepatitis B, Chronic	G S L	View
7	24316031	I195M	S	S	Hepatitis B, Chronic	G L	View
8	24316031	M204I	RT	P	Hepatitis B, Chronic	G S L	View
9	24316031	M204V	RT	P	Hepatitis B, Chronic	G S L	View
10	24316031	S53N	RT	P	Hepatitis B, Chronic	G S L	View
11	24316031	T47K	S	S	Hepatitis B, Chronic	G L	View
12	24316031	V173L	RT	P	Hepatitis B, Chronic	G S L	View
13	24316031	V191I	RT	P	Hepatitis B, Chronic	G S L	View
14	24316031	W182X	S	S	Hepatitis B, Chronic	G L	View
15	24316031	W196L	S	S	Hepatitis B, Chronic	G L	View
16	24316031	W196S	S	S	Hepatitis B, Chronic	G L	View
17	24316031	T47A	S	S	Hepatitis B, Chronic	G L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.